Trial intelligence / Profile preview

Zishen Zhuanggu Tablets in Primary Osteoporosis

CTR20131568Phase 2Active

Sponsor
Nanjing University of Chinese Medicine
Start
Jan 2015
Countries
1
01

Overview

A Phase 2 trial of Zishen Zhuanggu Tablets in involutional osteoporosis, sponsored by Nanjing University of Chinese Medicine. Started Jan 2015; status: active.

02

Drugs

Zishen Zhuanggu Tablets
03

Conditions

involutional osteoporosis

Beyond the preview

Go deeper on CTR20131568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call